InspireMD faces Nasdaq minimum bid price deficiency
Rhea-AI Filing Summary
InspireMD, Inc. received a notice from Nasdaq on July 17, 2026 that its common stock no longer meets the minimum $1.00 per share bid price requirement for continued listing on The Nasdaq Capital Market, based on 30 consecutive business days from June 3 through July 16, 2026.
The stock continues to trade on Nasdaq under the symbol NSPR and the notice has no immediate effect. InspireMD has 180 calendar days, until January 13, 2027, to regain compliance by achieving a closing bid of at least $1.00 for at least ten consecutive business days, a period Nasdaq may extend at its discretion.
If compliance is not regained, the company may qualify for an additional 180-day period if other listing standards are met and it notifies Nasdaq of a plan to cure the deficiency, potentially including a reverse stock split. Otherwise, its common stock could become subject to delisting, with a right to appeal. InspireMD plans to monitor its share price and evaluate options but provides no assurance it will regain compliance.
Positive
- None.
Negative
- Nasdaq minimum bid price non-compliance and delisting risk: InspireMD’s stock failed to meet the $1.00 minimum bid for 30 consecutive business days, triggering a Nasdaq notice, a 180-day cure period to January 13, 2027, and potential delisting if compliance is not restored or extended.
Filing Explained
A reverse stock split is identified only as a possible future cure, not an action taken in this filing; if effected, it would reduce the share count and raise the per-share price proportionally, without changing company value by the split itself.
8-K Event Classification
2 items: 3.01, 9.01
2 items
Item 3.01
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Securities
The company received a delisting notice, failed to satisfy a continued-listing rule or standard, or transferred its listing.
Item 9.01
Financial Statements and Exhibits
Exhibits
Financial statements, pro forma financial information, or exhibit attachments filed with this report.
Key Figures
Minimum bid price requirement: $1.00 per share
Non-compliance observation period: 30 consecutive business days
Initial compliance period: 180 calendar days
+2 more
5 metrics
Minimum bid price requirement
$1.00 per share
Nasdaq Listing Rule 5550(a)(2) threshold for The Nasdaq Capital Market
Non-compliance observation period
30 consecutive business days
Closing bid prices from June 3, 2026 through July 16, 2026
Initial compliance period
180 calendar days
Period to regain bid price compliance ending January 13, 2027
Minimum compliant duration
ten consecutive business days
Days closing bid must be at least $1.00 per share within compliance period
Potential additional compliance period
180 calendar days
Second period if other Nasdaq initial listing standards and conditions are satisfied
Key Terms
Nasdaq Listing Rule 5550(a)(2), minimum bid price requirement, Nasdaq Listing Rule 5810(c)(3)(A), reverse stock split, +1 more
5 terms
Nasdaq Listing Rule 5550(a)(2) regulatory
"not in compliance with the minimum bid price requirement under Nasdaq Listing Rule 5550(a)(2)"
minimum bid price requirement financial
"requires listed securities to maintain a minimum bid price of $1.00 per share"
A minimum bid price requirement is a rule that a stock must trade above a set price for a specified period to stay listed on an exchange. It matters to investors because falling below that threshold can trigger warnings or removal from the exchange, which can cut liquidity, reduce visibility, and often lead to sharper declines in share value—think of it like a venue’s minimum dress code that, if not met, can bar a performer from the stage.
Nasdaq Listing Rule 5810(c)(3)(A) regulatory
"In accordance with Nasdaq Listing Rule 5810(c)(3)(A), the Company has been provided a compliance period"
reverse stock split financial
"including, if necessary, by effecting a reverse stock split"
A reverse stock split reduces a company's number of outstanding shares while raising the price per share proportionally, so the total value of each investor's holding is unchanged; a 1-for-10 split turns 100 shares worth $1 each into 10 shares worth $10 each. Companies often do this to regain compliance with an exchange's minimum price rule or to attract investors who avoid very low-priced stocks.
Nasdaq Hearings Panel regulatory
"the Company would have the opportunity to appeal Nasdaq’s determination to a Nasdaq Hearings Panel"
A Nasdaq hearings panel is a group of experts that reviews cases when a company's stock listing is at risk of being removed from the exchange. They evaluate whether the company has met certain standards and determine if it can keep trading on Nasdaq. This process matters to investors because it can affect a company's ability to raise money and maintain credibility in the market.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What Nasdaq compliance issue did InspireMD (NSPR) disclose?
InspireMD disclosed it received a Nasdaq notice on July 17, 2026 for failing the $1.00 minimum bid price requirement. The stock traded below $1.00 for 30 consecutive business days, putting its Nasdaq Capital Market listing at risk if compliance is not restored.
How long does InspireMD (NSPR) have to regain Nasdaq bid price compliance?
InspireMD has an initial 180-calendar-day compliance period, ending January 13, 2027, to restore its bid price to at least $1.00. The closing bid must meet or exceed $1.00 for ten consecutive business days during this window, subject to Nasdaq’s discretion.
Can InspireMD (NSPR) receive more time beyond January 13, 2027?
InspireMD may receive an additional 180-day compliance period if it meets all initial Nasdaq Capital Market listing standards other than bid price. It must also satisfy the market value of publicly held shares requirement and notify Nasdaq of plans to cure, potentially via reverse stock split.
What happens if InspireMD (NSPR) cannot regain Nasdaq compliance?
If InspireMD does not regain compliance and is ineligible for, or fails during, any additional period, Nasdaq may notify the company that its common stock will be subject to delisting. InspireMD would then have the opportunity to appeal to a Nasdaq Hearings Panel.
What actions is InspireMD (NSPR) considering to address the Nasdaq deficiency?
InspireMD states it will monitor the closing bid price and evaluate options to regain compliance. Potential actions include effecting a reverse stock split. However, the company cautions there is no assurance it will successfully regain or maintain Nasdaq listing compliance.
Does the Nasdaq notice immediately affect trading of InspireMD (NSPR) stock?
The Nasdaq notice has no immediate effect on trading. InspireMD’s common stock continues to trade on The Nasdaq Capital Market under the symbol NSPR while the company works within the defined compliance periods to address the bid price deficiency.
AI-generated analysis. How Rhea-AI works. Not financial advice.
